Search

Author/Creator Higham, Steve

3. Safety and efficacy of pioglitazone for the delay of cognitive impairment in people at risk of Alzheimer's disease (TOMMORROW): a prognostic biomarker study and a phase 3, randomised, double-blind, placebo-controlled trial. Issue 7 (July 2021)

Authors:
Burns, Daniel K; Alexander, Robert C; Welsh-Bohmer, Kathleen A; Culp, Meredith; Chiang, Carl; O'Neil, Janet; Evans, Rebecca M; Harrigan, Patrick; Plassman, Brenda L; Burke, James R; Wu, Jingtao; Lutz, Michael W; Haneline, Stephen; Schwarz, Adam J; Schneider, Lon S; Yaffe, Kristine; Saunders, Ann ...
Journal:
Lancet neurology
Issue:
Volume 20:Issue 7(2021)
Page Start:
537
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search